High Growth Tech Stocks In Asia To Watch August 2025
Top 10 High Growth Tech Companies In Asia
Name
Revenue Growth
Earnings Growth
Growth Rating
Accton Technology
22.05%
23.29%
★★★★★★
Gold Circuit Electronics
20.97%
26.54%
★★★★★★
Zhejiang Lante Optics
21.61%
23.73%
★★★★★★
Shanghai Huace Navigation Technology
24.51%
23.48%
★★★★★★
PharmaEssentia
31.60%
57.71%
★★★★★★
Fositek
30.51%
37.34%
★★★★★★
Eoptolink Technology
32.53%
32.58%
★★★★★★
eWeLLLtd
24.95%
24.40%
★★★★★★
Shengyi Electronics
26.23%
37.40%
★★★★★★
CARsgen Therapeutics Holdings
81.53%
96.08%
★★★★★★
Click here to see the full list of 167 stocks from our Asian High Growth Tech and AI Stocks screener.
Let's explore several standout options from the results in the screener.
Shengyi TechnologyLtd
Simply Wall St Growth Rating: ★★★★★☆
Overview: Shengyi Technology Co., Ltd. is engaged in the development, manufacturing, and sale of laminates in China with a market capitalization of CN¥104.26 billion.
Operations: Shengyi Technology Co., Ltd. focuses on producing and distributing laminates within the Chinese market.
Shengyi Technology Co., Ltd, recently added to the SSE 180 Index, demonstrates robust growth metrics that underscore its upward trajectory in the tech sector. With a notable annual earnings increase of 46%, outpacing the electronic industry's average of 2.8%, and revenue projected to rise at 15.7% per year—faster than the broader Chinese market's 12.5%—the company is positioned well against its peers. Its commitment to innovation is evident from an R&D focus that aligns with forecasted high returns on equity of 20.8% in three years, signaling potential for sustained competitive advantage and shareholder value creation in a dynamic industry landscape.
Click to explore a detailed breakdown of our findings in Shengyi TechnologyLtd's health report.
Evaluate Shengyi TechnologyLtd's historical performance by accessing our past performance report.
Suzhou Dongshan Precision Manufacturing
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Suzhou Dongshan Precision Manufacturing Co., Ltd. is a company engaged in the production of precision components and electronic products, with a market cap of CN¥106.61 billion.
Operations: Dongshan Precision focuses on producing precision components and electronic products. The company operates with a market cap of CN¥106.61 billion, indicating its significant presence in the industry.
Suzhou Dongshan Precision Manufacturing, amidst a challenging environment with a recent 29.7% dip in earnings, still shows promise with its strategic moves and robust revenue forecasts. The company's commitment to growth is evident from its aggressive share buybacks, repurchasing 0.25% of its shares for CNY 100.08 million, signaling confidence in its future prospects. Despite a dividend cut this year, the firm's projected annual revenue growth at 14.7% outpaces the broader Chinese market's expectation of 12.5%, coupled with an anticipated earnings surge of 37.5% per annum over the next three years—highlighting potential resilience and adaptability in the high-growth tech landscape of Asia.
Navigate through the intricacies of Suzhou Dongshan Precision Manufacturing with our comprehensive health report here.
Gain insights into Suzhou Dongshan Precision Manufacturing's historical performance by reviewing our past performance report.
Richinfo Technology
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Richinfo Technology Co., Ltd. focuses on developing and selling software products in China, with a market capitalization of CN¥12.78 billion.
Operations: Richinfo Technology Co., Ltd. specializes in creating and marketing software products across China. The company generates revenue primarily through its software sales, with a notable focus on innovation and technology development within the sector.
Richinfo Technology, amidst a backdrop of board reshuffles and strategic amendments in governance, shows a robust trajectory with an 18.5% annual revenue growth outpacing the Chinese market forecast of 12.5%. Despite a recent dip in earnings by 36.8%, the company's forward-looking measures, including substantial dividend payouts totaling CNY 1.25 per share and anticipated earnings growth at an impressive rate of 24.5% annually, underscore its resilience and potential within Asia's competitive tech landscape. This outlook is further bolstered by its commitment to innovation as evidenced by significant R&D investments aimed at sustaining long-term growth in evolving technological domains.
Click here and access our complete health analysis report to understand the dynamics of Richinfo Technology.
Review our historical performance report to gain insights into Richinfo Technology's's past performance.
Make It Happen
Click through to start exploring the rest of the 164 Asian High Growth Tech and AI Stocks now.
Shareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments.
Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.
Ready For A Different Approach?
Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include SHSE:600183 SZSE:002384 and SZSE:300634.
Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@simplywallst.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
9 minutes ago
- Yahoo
Carry Wealth Holdings Leads The Charge In Asian Penny Stocks
Amidst a backdrop of global economic uncertainty, Asian markets have been navigating the complexities of trade tensions and fluctuating economic data. In such times, investors often look beyond established giants to explore opportunities in smaller or newer companies, sometimes referred to as penny stocks. Although the term may seem outdated, these stocks can still present valuable opportunities when backed by strong financials and growth potential. This article explores three Asian penny stocks that stand out for their balance sheet resilience and potential for significant returns. Top 10 Penny Stocks In Asia Name Share Price Market Cap Financial Health Rating Food Moments (SET:FM) THB4.10 THB4.05B ★★★★★☆ Lever Style (SEHK:1346) HK$1.48 HK$933.81M ★★★★★★ TK Group (Holdings) (SEHK:2283) HK$2.39 HK$1.99B ★★★★★★ CNMC Goldmine Holdings (Catalist:5TP) SGD0.515 SGD208.72M ★★★★★☆ T.A.C. Consumer (SET:TACC) THB4.66 THB2.8B ★★★★★★ China Sunsine Chemical Holdings (SGX:QES) SGD0.73 SGD695.97M ★★★★★★ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.53 SGD9.96B ★★★★★☆ Livestock Improvement (NZSE:LIC) NZ$1.00 NZ$142.34M ★★★★★★ Rojana Industrial Park (SET:ROJNA) THB4.70 THB9.5B ★★★★★★ BRC Asia (SGX:BEC) SGD3.57 SGD979.43M ★★★★★★ Click here to see the full list of 987 stocks from our Asian Penny Stocks screener. Let's review some notable picks from our screened stocks. Carry Wealth Holdings Simply Wall St Financial Health Rating: ★★★★★★ Overview: Carry Wealth Holdings Limited is an investment holding company that manufactures, trades, and markets garment products for various brands across the United States, Mainland China, Europe, Hong Kong, and internationally with a market cap of HK$431.93 million. Operations: The company's revenue is primarily derived from its Garment Manufacturing and Trading segment, which generated HK$664.69 million. Market Cap: HK$431.93M Carry Wealth Holdings Limited, with a market cap of HK$431.93 million, primarily generates revenue from its Garment Manufacturing and Trading segment. Despite being unprofitable, the company is debt-free and maintains a strong cash runway exceeding three years based on current free cash flow. Recent board changes introduced experienced financial professionals, potentially strengthening oversight. However, high share price volatility persists alongside negative return on equity at -22.85%. While short-term assets comfortably cover liabilities, both management and board tenures are relatively short, indicating an evolving leadership team as the company navigates its challenges in the competitive garment industry. Jump into the full analysis health report here for a deeper understanding of Carry Wealth Holdings. Review our historical performance report to gain insights into Carry Wealth Holdings' track record. Qinghai Spring Medicinal Resources Technology Simply Wall St Financial Health Rating: ★★★★★★ Overview: Qinghai Spring Medicinal Resources Technology Co., Ltd. operates in the medicinal resources sector and has a market cap of approximately CN¥25.01 billion. Operations: Qinghai Spring Medicinal Resources Technology Co., Ltd. has not reported specific revenue segments. Market Cap: CN¥2.5B Qinghai Spring Medicinal Resources Technology, with a market cap of CN¥25.01 billion, operates without significant revenue streams, indicating it may be pre-revenue. The company is debt-free and possesses a robust cash runway exceeding three years based on current free cash flow. Despite its unprofitability and negative return on equity at -15.54%, the management team and board are experienced, averaging tenures of 10.4 and 5.7 years respectively. Short-term assets significantly exceed liabilities, providing financial stability amidst challenges in achieving profitability as earnings have declined by 8.5% annually over the past five years. Navigate through the intricacies of Qinghai Spring Medicinal Resources Technology with our comprehensive balance sheet health report here. Learn about Qinghai Spring Medicinal Resources Technology's historical performance here. Zhejiang CONBA PharmaceuticalLtd Simply Wall St Financial Health Rating: ★★★★★★ Overview: Zhejiang CONBA Pharmaceutical Co., Ltd. focuses on the research, development, production, and sales of pharmaceuticals and health products in mainland China, with a market cap of CN¥11.53 billion. Operations: The company's revenue is primarily generated from its operations in China, amounting to CN¥6.38 billion. Market Cap: CN¥11.53B Zhejiang CONBA Pharmaceutical Co., Ltd. has shown financial resilience with a significant reduction in its debt to equity ratio from 63.8% to 3.9% over five years, and its short-term assets of CN¥4.5 billion comfortably cover both short and long-term liabilities. Despite a low return on equity at 8.7%, the company has maintained stable earnings growth, surpassing industry averages with a recent annual increase of 13.8%. However, its dividend track record remains unstable, and the board's average tenure of 1.6 years suggests limited experience in navigating market complexities effectively. Click here to discover the nuances of Zhejiang CONBA PharmaceuticalLtd with our detailed analytical financial health report. Assess Zhejiang CONBA PharmaceuticalLtd's previous results with our detailed historical performance reports. Make It Happen Explore the 987 names from our Asian Penny Stocks screener here. Curious About Other Options? Rare earth metals are the new gold rush. Find out which 25 stocks are leading the charge. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:643 SHSE:600381 and SHSE:600572. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
9 minutes ago
- Yahoo
All Nippon Airways finalizes takeover of Nippon Cargo Airlines
All Nippon Airways has finally acquired Nippon Cargo Airlines, the company announced late Sunday, ending a two year saga and creating the world's 14th largest airline group by tonnage transported. ANA postponed completing the deal eight times because of delays in regulatory reviews. Chinese competition authorities approved the deal, with conditions, in early July. The Japan Fair Trade Commission approved the transaction in January. The acquisition will help All Nippon Airways, which operates six Boeing 767 freighter aircraft and two Boeing 777 freighters, in addition to managing cargo carried by the company's passenger aircraft, expand its international air cargo network and related products to better support shippers. In 2023, ANA had nine 767 cargo jets in the fleet. Nippon Cargo Airlines owns and controls 15 Boeing 747 jumbo freighters: eight 747-8s it flies on its own, plus five older 747-400s operated on its behalf by U.S.-based Atlas Air and two 747-400s crewed by ASL Airlines Belgium. Japanese ocean and transport company Nippon Yusen Kabushiki Kaisha, also known as NYK Line, agreed in March 2023 to sell NCA to ANA, saying it faced challenges making the investments necessary to maintain the fleet as operating margins contracted. The companies took much longer than expected to finalize the deal because of difficulty receiving all approvals from nations where the companies operate, according to a high-level source with one of the companies. After initial delays, executives anticipated deal closure to happen in February 2024. Earlier this year, ANA said it expected to complete the transaction on May 1. 'The strategic integration of NCA's freighter network and specialized cargo expertise with the ANA Group's existing infrastructure will greatly improve our capability to serve our customers' needs,' said Koji Shibata, president and CEO of ANA Holdings. 'We are committed to leveraging this expanded capacity and combined knowledge to deliver exceptional value in our cargo transport solutions globally.' The final transfer of NCA shares to ANA occurred on Friday. Financial terms were not disclosed. ANA international cargo revenue for the fiscal year first quarter ended June 30 slipped 2% to $286.2 million despite a 2.5% increase in traffic volume. Demand fell for shipments from China to North America, but ANA offset the decline with more shipments from the rest of Asia to North America. Click here for more FreightWaves/American Shipper stories by Eric Kulisch. RELATED READING: Amazon launches dedicated cargo service to Colombia with 21 Air The post All Nippon Airways finalizes takeover of Nippon Cargo Airlines appeared first on FreightWaves. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Bloomberg
36 minutes ago
- Bloomberg
Modi Defiant as Trump Steps Up Pressure on India's Russian Oil Purchases
By , Rakesh Sharma, and Preeti Soni Save Indian Prime Minister Narendra Modi struck a defiant tone in the face of US President Donald Trump's tariff threats, urging the nation to buy local goods as his administration signaled it would continue buying Russian oil. Modi's government hasn't given India's oil refiners instructions to stop buying Russian oil, and no decision has been taken on whether to halt the purchases, people familiar with the situation told Bloomberg, asking not to be named due to the sensitivity of the matter. Both state-run and private refiners are allowed to buy from preferred sources, and crude purchases remain a commercial decision, several of the people said.
